3 completed, 1 suspended. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Suspended 1 |
Follow Dexmethylphenidate Hydrochloride: new trials by email Literature Review of Dexmethylphenidate Hydrochloride trials Research Report on Dexmethylphenidate Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 CTx-1301 - Dexmethylphenidate 6.25mg, CTx-1301 - Dexmethylphenidate 12.5mg, CTx-1301 - Dexmethylphenidate 18.75mg - ADHD, ADHD - Combined Type | Phase 3 | Suspended | Cingulate Therapeutics | 45 | 2023-07-31 | 2026-05-05 |
| Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR Dexmethylphenidate, Mixed Amphetamine Salts, ER, placebo - Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | Seattle Children's Hospital | 77 | 2006-01-01 | 2017-04-19 |
| Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Focalin XR - ADHD | Phase 3 | Completed | Novartis | 90 | 2005-06-01 | 2007-12-21 |
| Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Focalin XR - ADHD | Phase 3 | Completed | Novartis | 90 | 2005-05-01 | 2007-12-21 |
Attention Deficit Disorder with Hyperactivity (4)
Novartis (2) · Cingulate Therapeutics (1) · Seattle Children's Hospital (1)
United States (4)
Ann Childress, MD (1) · Elizabeth Charney, MD (1) · Mark A Stein, PhD (1) · Matt Brams, MD (1) · Matthew Brams, MD (1)